Table 1.

Clinical finding of the patients in total and subdivided to the different groups

	Total	ICUS	MDS	MDS-IB/EB	MDS/MPN
Patients	33	8	7	11	7
Male:female (ratio)	27:6 (4.5)	5:3 (1.67)	7:0	8:3 (2.67)	7:0
Median age (range) [years]	63 (36–84)	55 (36–75)	68 (58–84)	65 (44–77)	66 (55–75)
Samples	77	20	15	25	17
Cases with ≥ 2 follow-up samples	9 (27%)	2 (25%)	1 (14%)	3 (27%)	3 (43%)
Median follow-up (range) [months]	38 (2–130)	61.5 (14–110)	38 (3–73)	44 (5–130)	14 (2–47)
Median leucocytes (range) [/μl] [number of cases with available date]	3890 (750–45,770) [31]	3695 (1100–9000) [8]	4200 (2700–6300) [7]	2830 (750–14,820) [11]	7080 (4410–45,770) [5]
Median hemoglobin (range) [g/dl] [number of cases with available date]	10.5 (6.0–16.3) [30]	11.3 (6.8–14.1) [7]	9.5 (8.1–13.0) [7]	9.2 (6.0–13.2) [11]	13.8 (10.8–16.3) [5]
Median thrombocytes (range) [1000/μl] [number of cases with available date]	133 (5–389) [31]	153.5 (71–389) [8]	88 (37–301) [7]	79 (5–297) [11]	83 (33–202) [5]

ICUS idiopathic cytopenia of undetermined significance, MDS myelodysplastic syndrome, MDS-IB/EB myelodysplastic syndrome with increased blasts/excess blasts, MPN myeloproliferative neoplasm